Taro Pharmaceutical
TARO
$42.24
Share price
0.45%
Change (1 day)
72.76%
Change (1 year)
Categories
P/S ratio for Taro Pharmaceutical (TARO)
P/S ratio as of April 2024 (TTM): 2.60
According to Taro Pharmaceutical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.59905. At the end of 2023 the company had a P/S ratio of 2.57.
P/S ratio history for Taro Pharmaceutical from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 2.57 | 34.17% |
| 2022 | 1.92 | -42.37% |
| 2021 | 3.32 | -31.87% |
| 2020 | 4.88 | -6.43% |
| 2019 | 5.22 | 5.05% |
| 2018 | 4.96 | -19.23% |
| 2017 | 6.15 | 34.92% |
| 2016 | 4.56 | -36% |
| 2015 | 7.12 | -9.6% |
| 2014 | 7.88 | 31.14% |
| 2013 | 6.01 | 81.31% |
| 2012 | 3.31 | 27.49% |
| 2011 | 2.60 | 63.13% |
| 2010 | 1.59 | 63.44% |
| 2009 | 0.9745 | 4.42% |
| 2008 | 0.9333 | |
| 2005 | 1.35 | -61.22% |
| 2004 | 3.49 | -41.02% |
| 2003 | 5.92 | 15.96% |
| 2002 | 5.11 | -27.01% |
| 2001 | 7.00 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 3.75 | 44.30% | 🇺🇸 USA |
 Novartis NVS | 3.73 | 43.51% | 🇨🇭 Switzerland |
 Pfizer PFE | 2.46 | -5.32% | 🇺🇸 USA |
 Merck MRK | 5.28 | 103.26% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2.19 | -15.68% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | 0.9386 | -63.89% | 🇮🇱 Israel |